Literature DB >> 7678072

Monoclonal antibody to an external epitope of the human mdr1 P-glycoprotein.

R J Arceci1, K Stieglitz, J Bras, A Schinkel, F Baas, J Croop.   

Abstract

A membrane glycoprotein, termed P-glycoprotein, has been shown to be responsible for cross-resistance to a broad range of structurally and functionally distinct cytotoxic agents. P-glycoprotein, encoded in humans by the mdr1 gene, functions as an energy-dependent efflux pump to exclude these cytotoxic agents from the resistant cell. In order to study the phenomenon of multidrug resistance in both normal and neoplastic cells, we have generated a mouse monoclonal antibody directed to an external epitope of the human P-glycoprotein. This monoclonal antibody, 4E3, is an IgG2a class antibody which specifically recognizes the human mdr1 P-glycoprotein but not the mdr3 gene product. The 4E3 monoclonal antibody immunoprecipitates both the glycosylated and nonglycosylated forms of P-glycoprotein under mild denaturation conditions. In addition, 4E3 can detect P-glycoprotein in immunocytochemical analysis of fixed tissue-cultured cells and in analysis of frozen sections of human tissue. Binding of the monoclonal antibody to multidrug-resistant cells does not significantly affect the intracellular accumulation or potentiate the cytotoxicity of daunomycin in multidrug-resistant cells. However, at high concentrations of antibody, 4E3 produces a mild potentiation of vinblastine and actinomycin cytotoxicity in multidrug-resistant cells. This monoclonal antibody will be useful both for analyzing P-glycoprotein expression in normal and neoplastic cells and for isolating live cells expressing the P-glycoprotein without significantly affecting the efflux functions of the transporter.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7678072

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  17 in total

1.  Multidrug resistance increment in a human colon carcinoma cell line by colchicine.

Authors:  M J Ruiz Gómez; L Gil; A Souviron; M Martínez Morillo
Journal:  J Physiol Biochem       Date:  2000-03       Impact factor: 4.158

2.  BAX enhances paclitaxel-induced apoptosis through a p53-independent pathway.

Authors:  T Strobel; L Swanson; S Korsmeyer; S A Cannistra
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

3.  Detection of recombinant P-glycoprotein in multidrug resistant cultured cells.

Authors:  U A Germann
Journal:  Mol Biotechnol       Date:  2000-02       Impact factor: 2.695

4.  P-glycoprotein and alloimmune T-cell activation.

Authors:  Shona S Pendse; David M Briscoe; Markus H Frank
Journal:  Clin Appl Immunol Rev       Date:  2003-07

5.  Increased expression of multidrug resistance related proteins Pgp, MRP1, and LRP/MVP occurs early in colorectal carcinogenesis.

Authors:  G A Meijer; A B Schroeijers; M J Flens; S G Meuwissen; P van der Valk; J P Baak; R J Scheper
Journal:  J Clin Pathol       Date:  1999-06       Impact factor: 3.411

6.  Role of P-glycoprotein in restricting propranolol transport in cultured rabbit conjunctival epithelial cell layers.

Authors:  J J Yang; K J Kim; V H Lee
Journal:  Pharm Res       Date:  2000-05       Impact factor: 4.200

7.  Production of monoclonal antibodies to P-glycoprotein: its application in detection of soluble and surface P-glycoprotein of leukemia patients.

Authors:  Sawitree Chiampanichayakul; Songyot Anuchapreeda; Nuttapol Chruewkamlow; Kodchakorn Mahasongkram; Pattra Thanaratanakorn; Watchara Kasinrerk
Journal:  Int J Hematol       Date:  2010-08-26       Impact factor: 2.490

8.  New immunohistochemical "sandwich" staining method for mdr1 P-glycoprotein detection with JSB-1 monoclonal antibody in formalin-fixed, paraffin-embedded human tissues.

Authors:  K Tóth; M M Vaughan; H K Slocum; M A Arredondo; H Takita; R M Baker; Y M Rustum
Journal:  Am J Pathol       Date:  1994-02       Impact factor: 4.307

9.  A physiologic function for p-glycoprotein (MDR-1) during the migration of dendritic cells from skin via afferent lymphatic vessels.

Authors:  G J Randolph; S Beaulieu; M Pope; I Sugawara; L Hoffman; R M Steinman; W A Muller
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

Review 10.  Antibodies in the study of multiple drug resistance.

Authors:  Y Heike; T Tsuruo
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.